Researchers have uncovered crucial link that offers a new and potent way to target childhood cancers.
Researchers have discovered how the modified natural compound dextran-catechin disrupts formation of blood vessels that fuel growth in the childhood cancer neuroblastoma.
Australian scientists have discovered the mechanism that accelerates the childhood cancer neuroblastoma and identifed an experimental drug with the potential to stop the disease in its tracks.
Professor Michelle Haber has won the NSW Cancer Institute's top honour for her ground-breaking translational research, which has led to increased survival rates for children with cancer.
In a world-first, UNSW researchers have developed a nanoparticle that could improve the effectiveness of chemotherapy for neuroblastoma by a factor of five.
Research into the biology of brain cancer by the Children’s Cancer Institute has been recognised as one of the top 10 medical research projects in Australia.
Scientists at the Lowy Cancer Research Centre say a new treatment approach for childhood cancer may also offer hope to adults with lung cancer.
Three world-first clinical trials to tackle one of the most common and aggressive childhood cancers have been backed by $6 million in federal government funding.